WALTHAM, Mass. — For many biotech executives, an invitation to speak at the annual J.P. Morgan Healthcare Conference in San Francisco is tantamout to an invitation in Hollywood to walk the red carpet on Oscar night. It’s unmistakeable proof that you’ve arrived.
Praveen Tipirneni, CEO of Morphic Therapeutic, certainly felt that way about his first chance to address colleagues. But the offer also started a sideline interest that couldn’t seem more removed from drug development: drawing cartoons.